Abstract : Carbapenemase-producing Enterobacteriaceae CPE have been reported worldwide, but the types of carbapenemase vary between countries. Metallo-betalactamase MBL IMP bla IMP is the most common type of carbapenemase in Japan. CPE outbreaks occurred in our hospital s neonatal intensive care unit NICU between October 2014 and October 2015. The aim of this study was to evaluate the results of active surveillance and to establish more effective CPE detection methods. We also investigated the molecular epidemiological characteristics of CPE in Japan. During the outbreak period, active surveillance was performed on a weekly basis by analyzing fecal cultures from all patients admitted to the NICU. Between January 2014 and December 2015, which included the outbreak period described above, Enterobacteriaceae strains isolated by fecal culture or from clinical specimens were analyzed by antimicrobial susceptibility testing and double-disc synergy testing DDST using ceftazidime or imipenem with sodium mercaptoacetic acid, polymerase chain reaction PCR , pulsed-eld gel electrophoresis PFGE , and conjugal transfer experiments. During the outbreak period we analyzed 1073 isolates detected by fecal culture from 285 patients. Of these, we detected 64 bla IMP -producing Enterobacteriaceae from 52 patients, all of whom were asymptomatic carriers 52/285, 18.2 . Klebsiella pneumoniae 33/64 strains, 51.6
Introduction
The spread of carbapenemase-producing Enterobacteriaceae CPE is a serious problem in healthcare settings. These strains are typically resistant to almost all available antimicrobials, increasing the risk of mortality following infection 1, 2 . CPE-colonized patients can unwittingly spread infection and cause an outbreak of infectious disease. Detection of CPE is based on polymerase chain reaction PCR analysis. However, some CPE strains are susceptible to carbapenems and can remain undetected if antimicrobial susceptibility tests and PCR targeting carbapenem-resistant Enterobacteriaceae only are employed.
The most common carbapenemase in Japan is metallo-beta-lactamase MBL IMP bla IMP , which was rst detected in Japan in 1991 3 . The gene encoding bla IMP is carried on a plasmid, which plays an important role in its transmission during healthcare-associated outbreaks 4 . Thus, active surveillance of patients at high risk of CPE colonization, by taking stool or rectal swabs, is strongly recommended 5 . In Japan, CPE outbreaks have been controlled by the careful use of antibiotics, strict hygiene practices, and strict compliance with contact precautions 6, 7 .
Despite the precautions described above, there are insuf cient data regarding infection control methodology, active surveillance, and the molecular epidemiological characteristics of CPE during outbreaks in Japan [6] [7] [8] . In this study, we collected CPE isolates between January 1, 2014 and December 31, 2015, which included a year-long CPE outbreak at our hospital s neonatal intensive care unit NICU . We performed active surveillance and investigated the drug-resistance, types of resistance genes, transmission mechanism, and plasmid content of CPE isolates to gain a better understanding of CPE outbreaks in Japan.
Materials and methods

Setting and outbreak details
Showa University Hospital is an 815-bed tertiary care hospital in Tokyo, Japan. In October 2014 CPE was isolated from 3 NICU patients : we judged this to be an outbreak of CPE. An outbreak of CPE occurred in the hospital s NICU comprising 38 beds between October 2014 and October 2015. During this outbreak period, we routinely screened fecal cultures from NICU patients every Tuesday during admission. In this outbreak period, 313 patients were included in this study, and fecal culture was obtained from 285 patients. Sheep blood and Drigalski agar media were used for screening samples. When CPE were isolated from fecal cultures, the affected patients were spatially isolated in speci c controlled areas within the NICU. Patients showing some clinical symptoms of infectious disease were regarded as infectious patients and those showing no symptoms were regarded as colonized patients. We discontinued acceptance of patients from other hospitals during the outbreak period. Hospitalization for in-hospital births was also restricted to a minimum to reduce the number of patients exposed to CPE. In addition, medical staff were repeatedly educated on contact prevention measures and hand hygiene.
Bacterial isolates, susceptibility testing, and phenotypic assay
All Enterobacteriaceae 6247 strains from 4434 patients isolated at Showa University Hospital between January 1, 2014 and December 31, 2015 were included in this study. Strains isolated from the same patient and site of isolation were counted as a single strain. Identi cation and antimicrobial susceptibility testing were performed using a MicroScan WalkAway 96 Siemens Healthineers and Siemens Medical Solutions USA, Inc., Malvern, PA, USA . We determined the minimum inhibitory concentration MIC for ampicillin, amoxicillin/clavulanic acid, piperacillin, piperacillin/tazobactam, cefazolin, cefmetazole, cefotaxime, ceftazidime, imipenem, meropenem, gentamicin, amikacin, minocycline, sulfamethoxazole-trimethoprim, and levo oxacin. MIC values were interpreted as susceptible S , intermediate I , or resistant R according to the approved standard published in the Clinical and Laboratory Standards Institute CLSI M100-S22.
To detect MBLs, the double-disc synergy test DDST was performed using Kirby-Bauer discs containing ceftazidime or imipenem with sodium mercaptoacetic acid Eiken Kagaku, Tokyo, Japan on strains that were either resistant to third-generation cephalosporins cefotaxime and ceftazidime or non-susceptible demonstrated full resistance or intermediate resistance to carbapenems imipenem and meropenem 9 . We de ned a positive DDST result as one that displayed any slight enlargement in the diameter of the inhibition zone, which suggested that the strain produced an MBL.
DNA extraction and PCR
To detect carbapenemase genes, PCR analysis was performed on strains that were either non-susceptible to carbapenems imipenem and meropenem , or resistant to third-generation cephalosporins cefotaxime and ceftazidime and DDST positive. Total bacterial DNA was extracted from colonies grown on Luria-Bertani LB medium agar plates. PCR was performed as described previously 10 , using 50 pmol of the forward F and reverse R primers shown in Table 1 . PCR products were electrophoresed on a 5 polyacrylamide gel and stained with SYBR Green Takara Bio Inc., Shiga, Japan .
Pulsed-eld gel electrophoresis PFGE PFGE was performed as described previously 11 . Genomic DNA was digested with the restriction enzyme Spe . Pulsing was performed by the lamp-pulse method at 60-90 s of switching for 22 h at 6 V/cm and at 14 C using the CHEF DR system Bio-Rad, Hercules, CA, USA . The PFGE patterns were analyzed using the Dendron computer software for Windows 3.1 Soltech, Oakdale, CA, USA . The Dendron calculated the similarity value S AB for each pair of ngerprints on the basis of band position.
Conjugal transfer experiments
Conjugal transfer experiments were performed using rifampicin-resistant and cefotaximesusceptible E. coli TUM2235 strains provided by Toho University Tokyo, Japan as the recipients. Eight strains of bla IMP -producing Enterobacteriaceae isolated from patients were used as the donors. All of the donors were susceptible to rifampicin. Both donor and recipient isolates were incubated for 4 h in LB broth at 37 C and diluted to approximately 1.5 10 8 CFU/ml using
McFarland s nephelometer standard number of 0.5. Donor broth 1 ml was mixed with 250 µl of recipient broth and incubated for 24 h at 35 C. The conjugation mixture was spread onto an LB agar plate containing 25 µg/ml of rifampicin and 2.5 µg/ml of cefotaxime to select transconjugants. Colonies were incubated overnight at 37 C and used for plasmid DNA extraction. MBL production was con rmed by DDST.
Plasmid DNA extraction and sequencing
We sequenced one of the transconjugant plasmid DNA. This strain was Enterobacter cloacae that was isolated from NICU patient s surveillance fecal culture, and fully resistant to imipenem and meropenem, and showed intermediate resistance to amikacin. Plasmid DNA was extracted from overnight cultures of 2 yeast extract tryptone broth using the QIAGEN Plasmid Maxi Kit QIAGEN, Hilden, Germany according to the manufacturer s instructions. Sequencing reactions were performed using the BigDye Terminator v1.1 Cycle Sequencing kit Thermo Fisher Scienti c, Waltham, MA, USA according to the manufacturer s instructions, and products were sequenced on an ABI PRISM 310 Genetic Analyzer Life Technologies, Gaithersburg, MD, USA . Database searches were conducted using the BLAST server http://www.ncbi.nlm.nih.gov/ BLAST .
This was a retrospective study, and consent was obtained by opt-out. Approval for this study was obtained from the Ethics Committee at Showa University School of Health and Science Kanagawa, Japan ; approval number 363 . 
Results
Bacterial isolates and detection of carbapenem-resistance genes
During the whole study period January 2014 to December 2015 , 6247 strains 4434 patients of Enterobacteriaceae were isolated from infected patients or by preventive screening of patients at Showa University Hospital. Of these, 151 strains were non-susceptible to carbapenems, resistant to third-generation cephalosporins, and gave a positive DDST result. PCR analysis revealed that 124 of these 151 strains carried the bla IMP gene. All 124 strains harboring the bla IMP gene gave a positive DDST result. Other types of carbapenemase, such as KPC, VIM-2, OXA-48, and NDM-1, were not detected Table 2 . Of the 124 bla IMP -producing Enterobacteriaceae, 117 strains were isolated from 91 patients who were colonized with these bacteria, and 7 strains caused infection in 6 patients.
During the outbreak period October 2014 to October 2015 , 313 patients were admitted to the NICU. Fecal cultures from 285 patients 1073 samples were screened. Of these 1073 samples, 63 strains 53 patients were non-susceptible to imipenem or meropenem, and 8 carbapenem-susceptible strains 8 patients , which DDST con rmed to be MBL-producers, demonstrated resistance to cefotaxime or ceftazidime. PCR revealed that 64 of these 71 strains isolated from 52 of the 58 patients carried the bla IMP gene Table 2 . The predominant bla IMP -producing Enterobacteriaceae were Klebsiella pneumoniae 33/64 strains, 51. 6 and Enterobacter cloacae 20/64 strains, 31.3 . Each of these 64 bla IMP -producing Enterobacteriaceae were isolated from fecal culture samples following active surveillance of colonized patients, none of whom developed an infection. Of the bla IMP -producing Enterobacteriaceae, 18 strains 18/64, 28.1 were susceptible to imipenem and 7 strains 7/64, 11.7 were susceptible to meropenem Table 3 . Because meropenem susceptibility test was started using routinely from October 2014 in our hospital, the results of the meropenem susceptibility test could not be obtained for 4 cases Table  3 . Six bla IMP -producing Enterobacteriaceae were susceptible to both imipenem and meropenem Table 4 . One bla IMP -producing Enterobacteriaceae was susceptible to imipenem but was not 
PFGE
We used PFGE to analyze 31 strains of K. pneumoniae, 21 strains of E. cloacae, and 5 strains of Klebsiella oxytoca that were isolated from the NICU during the outbreak period. Several genome patterns were observed Fig. 1 . Samples 11, 12 , 51, and 54 were categorized into group A Fig. 1, 2 . Sample 53 had a unique digestion pattern, and sample 55 was categorized into group B by subsequent PFGE analysis Fig. 1, 2 .
Dendrograms based on computer-assisted comparisons of the PFGE profiles of the 21 E. cloacae strains are shown in Fig. 2 . The PFGE pro les could be divided into 3 clusters when the S AB cut-off value was set at 0.75. K. pneumoniae and K. oxytoca strains were divided into 9 and 2 clusters, respectively, using the same procedure. The results of the antimicrobial susceptibility tests, including those for carbapenems, varied among isolates within the same cluster. Of 
Double-disc synergy testing DDST was performed using sodium mercaptoacetic acid with ceftazidime and imipenem.
Abbreviations : MIC, minimum inhibitory concentration ; N/A, not available.
the 7 the Enterobacter species with a negative PCR result, 3 strains were analyzed by PFGE and were found to belong to different PFGE clusters.
Conjugal transfer experiment and sequencing
Eight strains of bla IMP -producing Enterobacteriaceae isolated from patients were used as donors. These included : 4 E. cloacae strains, 3 K. pneumoniae strains, and one K. oxytoca strain. They were selected based on the results of the PFGE. All 8 donors successfully transferred plasmids to recipients, and all of the resulting transconjugants were shown to produce MBL by DDST. A class I integron coding for integrase I, the att recombination site, bla IMP -11, and aac 6 -Ia was identi ed by sequencing the plasmid DNA extracted from one of the transconjugants Fig. 3 . E. cloacae carrying the transconjugant plasmid described above was fully resistant to imipenem and meropenem, and showed intermediate resistance to amikacin.
Discussion
In this study we describe a large, widespread outbreak of 64 bla IMP -producing Enterobacteriaceae in the NICU at a Japanese university hospital. Detecting CPE can be dif cult if only a routine antimicrobial susceptibility test is used because the MIC values of carbapenems are variable 12, 13 . In this study, the MIC values ranged from ≤ 1 to ≥ 4 µg/ml. Instead, we used a strategy in which MBL-producing pathogens were detected by DDST prior to genetic analysis. This may be an effective strategy because it reduces the time and cost required for detection Enterobacter cloacae isolates The PFGE profiles were divided into 3 clusters, Groups A, B, and C, when the cutoff of the SAB similarity value was set at 0.75.
especially in regions where MBL-producing pathogens are predominant, such as Japan 14 .
Using our strategy, we analyzed isolates that were non-susceptible to carbapenem and isolates that produced MBL and were resistant to third-generation cephalosporins to detect carbapenemsusceptible CPE. We identi ed 7 bla IMP -positive isolates with carbapenem susceptibility. We also detected 7 bla IMP -negative strains by PCR. However, 4 of the bla IMP -negative strains had positive DDST results, and may encode other IMP subtypes that could not be determined in this study. The remaining 3 strains had negative DDST results and were resistant to carbapenem, which may be the result of a decrease in porin expression and beta-lactamase expression but not MBL. Various subtypes of IMP-type metallo--lactamases have been reported, such as IMP-1 and IMP-6 that were reported in Japan 6, 8, 14 . In this study, the transconjugant plasmid DNA we sequenced possessed the bla IMP-11 gene ; however, we did not identify the IMP subtypes in the other strains. For effective infection control, it is important to understand how CPE spreads in healthcare settings. MBL genes are harbored by integrons in a transferable plasmid and can be easily transferred from one bacterium to another 15, 16 . We observed various clusters within each bacterial strain and many unique patterns among the isolates in our PFGE analysis. This may suggest that our outbreak was not only caused by the spread of a pathogen from a single clone, but also by horizontal transfer via a plasmid. Our conjugal transfer experiments also indicated that bla IMP -producing Enterobacteriaceae isolated from patients can transfer plasmids to another strain of Enterobacteriaceae, Escherichia coli. Sequencing the transconjugant plasmid DNA revealed that the transferable plasmid contained a class I integron harbouring the bla IMP -11 and aac 6 -Ia genes. As Enterobacteriaceae are a normal part of the intestinal ora, CPE can colonize the human colon over a long time period. Therefore, a delay in detecting CPE-colonized patients can result in the spread of CPE. The United States Centers for Disease Control and Prevention recommend active surveillance testing of individuals with epidemiologic links to a patient with CPE infection in acute care facilities, especially those located in endemic areas 5 . In this study, 285
out of 313 91.1 patients admitted to the NICU during the outbreak period were subjected to active surveillance by fecal culture. Out of 1073 samples obtained from the 285 patients, 64 Fig. 3 . Structure of the integron region in plasmid DNA isolated from a transconjugant The plasmid DNA was extracted from a bla IMP-producing E. cloacae strain and sequenced. This class I integron structure contained carbapenem and aminoglycoside resistant gene blaIMP-11 and aac 6 -Ia. The sequence was submitted to GenBank with the accession number LC179842.
strains 64/1073, 6.0 of CPE were isolated and 52 colonized patients 52/285, 18.2 were detected. Active surveillance identi ed more CPEs in the NICU during the outbreak period compared to the 124 CPE isolated from 6247 Enterobacteriaceae strains 2.0 during the whole study period. Since many CPE carriers were identi ed at the NICU, strict control measures were implemented, such as contact prevention measures, limiting the number of hospitalizations, and isolating carriers. In doing so, we succeeded in terminating the CPE outbreak at the NICU.
We have shown that active surveillance by fecal culturing and DDST of carbapenem-resistant and third-generation cephalosporin-resistant pathogens is an effective strategy for identifying CPE carriers. We believe this strategy may contribute to infection control and prevent further spread of disease in healthcare settings.
